Beta-Propiolactone → 4-(2-chloro-5-cyano-3-((7-cyano-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-N,N-dimethyl-1-(oxetan-3-yl)piperazine-2-carboxamide
Reaction equation
[Cl:1][C:2]1[C:7]([NH:8][C:9]2[N:14]=[C:13]([NH:15][CH:16]3[CH2:18][CH2:17]3)[C:12]3=[N:19][CH:20]=[C:21]([C:22]#[N:23])[N:11]3[N:10]=2)=[CH:6][C:5]([C:24]#[N:25])=[CH:4][C:3]=1[N:26]1[CH2:31][CH2:30][NH:29][CH:28]([C:32]([N:34]([CH3:36])[CH3:35])=[O:33])[CH2:27]1.[O:37]1[CH2:40][C:39](=O)[CH2:38]1.C(OC)(OC)OC.C([BH3-])#N.[Na+].O1CCC1=O>CO.CC(O)=O.O.C1COCC1>[Cl:1][C:2]1[C:7]([NH:8][C:9]2[N:14]=[C:13]([NH:15][CH:16]3[CH2:17][CH2:18]3)[C:12]3=[N:19][CH:20]=[C:21]([C:22]#[N:23])[N:11]3[N:10]=2)=[CH:6][C:5]([C:24]#[N:25])=[CH:4][C:3]=1[N:26]1[CH2:31][CH2:30][N:29]([CH:39]2[CH2:40][O:37][CH2:38]2)[CH:28]([C:32]([N:34]([CH3:36])[CH3:35])=[O:33])[CH2:27]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 4
Procedure
4-(2-chloro-5-cyano-3-((7-cyano-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-N,N-dimethylpiperazine-2-carboxamide (37 mg, 0.073 mmol, Example 563) was taken up in MeOH (0.2 mL) and THF (0.2 mL) and oxetan-3-one (9.38 μl, 0.146 mmol) and trimethyl orthoformate (0.081 mL, 0.731 mmol) were added. The reaction was stirred at room temperature for 3 h. Next, sodium cyanoborohydride (9.19 mg, 0.146 mmol) and one drop of AcOH were added and the reaction was stirred at room temperature overnight. Only a trace of product detected by LCMS, so an additional 2 eq. each of oxetanone and NaCNBH3 were added, and the reaction was heated at 50° C. for 8 h. The reaction was cooled to room temperature and an additional 2 eq. each of oxetanone and reducing agent were added. The reaction was stirred at room temperature over the weekend. An additional 2 eq. each of oxetanone and NaCNBH3 were added, along with 1 drop of AcOH, and the reaction was heated at 50° C. for 6 h. The reaction was cooled to room temperature and water was added; a yellow solid crashed out. The solid was collected by filtration and purified by preparative HPLC to provide 4-(2-chloro-5-cyano-3-((7-cyano-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-N,N-dimethyl-1-(oxetan-3-yl)piperazine-2-carboxamide (1.9 mg).
Workup
- stirringthe reaction was stirred at room temperature overnight
- temperaturethe reaction was heated at 50° C. for 8 h
- temperatureThe reaction was cooled to room temperature
- additionwere added
- stirringThe reaction was stirred at room temperature over the weekend
- temperaturethe reaction was heated at 50° C. for 6 h
- temperatureThe reaction was cooled to room temperature
- filtrationThe solid was collected by filtration
- custompurified by preparative HPLC
Sources & evidence
- ORD record
- ord-8cf8f8d796e3456ebe95bd74b53773a1
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09273057B2
Reaction notes
Loading…